Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Medtronic
AstraZeneca
Mallinckrodt
Cantor Fitzgerald
Fuji

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,559,305

« Back to Dashboard

Which drugs does patent 6,559,305 protect, and when does it expire?

Patent 6,559,305 protects ZYVOX and is included in three NDAs.

Protection for ZYVOX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty-one patent family members in thirty countries.

Summary for Patent: 6,559,305
Title: Linezolid--crystal form II
Abstract:The invention is a novel crystal form (Form II) of a known compound, linezolid ##STR1## which is useful as an antibacterial agent.
Inventor(s): Bergren; Michael S. (Portage, MI)
Assignee: Pharmacia & Upjohn Company (Kalamazoo, MI)
Application Number:10/154,359
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,559,305
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,559,305
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 6,559,305

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Pharmacia And Upjohn ZYVOX linezolid FOR SUSPENSION;ORAL 021132-001 Apr 18, 2000 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Pharmacia And Upjohn ZYVOX linezolid SOLUTION;INTRAVENOUS 021131-001 Apr 18, 2000 AP RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Pharmacia And Upjohn ZYVOX linezolid SOLUTION;INTRAVENOUS 021131-002 Apr 18, 2000 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Pharmacia And Upjohn ZYVOX linezolid SOLUTION;INTRAVENOUS 021131-003 Apr 18, 2000 AP RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Merck
McKesson
Daiichi Sankyo
Queensland Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.